Sale of Fullerton Health draws eight non-binding bids in 1st round: sources
Singapore
SIX years since Fullerton Healthcare Corp (Fullerton Health) ditched its much-publicised plan to list on the Singapore Exchange, its owners have put the corporate healthcare solutions firm on the block, even as signs of liquidity strain threaten to cloud its prospects.
But while healthcare-focussed firms seem all the rage now owing to the Covid-19 pandemic, the sale of Fullerton Health may be facing setbacks, particularly valuation-wise due to among other things, its somewhat complicated capital structure, The Business Times (BT) understands.
TRENDING NOW
If Europe goes to war, the fallout will be felt in East Asia
Indonesia stocks suffer worst plunge in nearly 30 years as MSCI proposes standalone status
China’s market is tougher than ever. Where can Singapore firms still find room to grow?
Nvidia CEO says ties to Singapore firm under spying probe were ‘normal’